A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...
Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...
TOKYO and CAMBRIDGE, Mass., Dec 14, 2023 - (JCN Newswire) - - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta (Abeta) monoclonal antibody "LEQEMBI ...
Allowing patients with heart failure to drink as much fluid as they want had no negative effects on safety outcomes — including hospitalization and death — and prevented discomfort related to thirst, ...
People with heart failure are often advised to limit their fluid intake. However, a large study led by Radboud University Medical Center now shows that this practice does not provide any health ...